Comments - Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors

被引:39
作者
Beuschlein, F
Schulze, E
Mora, P
Gensheimer, HP
Maser-Gluth, C
Allolio, B
Reincke, M
机构
[1] Univ Freiburg Klinikum, Innere Med Abt 2, Schwerpunkt Endokrinol, D-79106 Freiburg, Germany
[2] Univ Wurzburg, Med Klin, Schwerpunkt Endokrinol, D-8700 Wurzburg, Germany
[3] Heidelberg Univ, Inst Pharmakol, Heidelberg, Germany
关键词
D O I
10.1210/jc.83.7.2585
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Twenty-one hydroxylase (P450c21) is a key enzyme essential for normal zona glomerulosa and fasciculata function. Recently, 21-hydroxylase deficiency has been implicated in the pathogenesis of adrenocortical tumors. Therefore, we investigated the mutational spectrum of the CYP21B gene and the messenger RNA expression of P450c21 in six aldosterone-producing adenomas, seven cortisol-producing adenomas, two nonfunctional incidentally detected adenomas, and four adrenal carcinomas. DNA from leukocytes and tumors was amplified by PCR using primers specific for the CYP21B gene. The 10 exons, intron 2, intron 7, all other exon/intron junctions, and 380 bp of the promoter region of CYP21B were automatically sequenced. Poly(A) RNA was extracted from tumor tissue, dot blotted on a nylon membrane, and hybridized with P-32-labeled P450 side-chain cleavage, P450 17-alpha-hydroxylase, and P450c21 complementary DNA probes. We detected heterozygous germline mutations (exon 7, Val 281Leu) in two patients, one with a cortisol-producing adenoma and the other with an androgen-secreting adrenocortical carcinoma. A somatic, heterozygous microdeletion was found in exon 3 of one aldosterone-producing adenoma. The P450c21 gene expression correlated with the clinical phenotype of the tumor, with low P450c21 messenger RNA expression in nonfunctional adenomas (18.8%, 1.5%) compared with high P450c21 expression in aldosterone- and cortisol-producing adenomas (84 +/- 8% and 101 +/- 4%, respectively, us, normal adrenals, 100 +/- 10%). In conclusion, the prevalence of heterozygous germline mutations in the CYP21B gene was higher in patients with adrenocortical tumors (11%; 95% confidence interval, 1-34%) than in the general European population (2%; 95% confidence interval, 1.93-2.06%), but this difference is questionable because of the low number of subjects in our series. The pathophysiological significance of this finding in the presence of one normal CYP21B gene seems to be low, suggesting that 31-hydroxylase deficiency is not a major predisposing factor for adrenal tumor formation.
引用
收藏
页码:2585 / 2588
页数:4
相关论文
共 28 条
[1]   THE INCIDENTALLY DISCOVERED ADRENAL MASS [J].
COPELAND, PM .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (06) :940-945
[2]   Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees [J].
Day, DJ ;
Speiser, PW ;
Schulze, E ;
Bettendorf, M ;
Fitness, J ;
Barany, F ;
White, PC .
HUMAN MOLECULAR GENETICS, 1996, 5 (12) :2039-2048
[3]   ENDOCRINE ACTIVITY OF THE SILENT ADRENOCORTICAL ADENOMA IS UNCOVERED BY RESPONSE TO CORTICOTROPIN-RELEASING HORMONE [J].
HENSEN, J ;
BUHL, M ;
BAHR, V ;
OELKERS, W .
KLINISCHE WOCHENSCHRIFT, 1990, 68 (12) :608-614
[4]   EFFECTS OF INDIVIDUAL MUTATIONS IN THE P-450(C21) PSEUDOGENE ON THE P-450(C21) ACTIVITY AND THEIR DISTRIBUTION IN THE PATIENT GENOMES OF CONGENITAL STEROID 21-HYDROXYLASE DEFICIENCY [J].
HIGASHI, Y ;
HIROMASA, T ;
TANAE, A ;
MIKI, T ;
NAKURA, J ;
KONDO, T ;
OHURA, T ;
OGAWA, E ;
NAKAYAMA, K ;
FUJIIKURIYAMA, Y .
JOURNAL OF BIOCHEMISTRY, 1991, 109 (04) :638-644
[5]   ADRENAL INCIDENTALOMA AND PATIENTS WITH HOMOZYGOUS OR HETEROZYGOUS CONGENITAL ADRENAL-HYPERPLASIA [J].
JARESCH, S ;
KORNELY, E ;
KLEY, HK ;
SCHLAGHECKE, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (03) :685-689
[6]   INCIDENTALLY DISCOVERED ADRENAL MASSES [J].
KLOOS, RT ;
GROSS, MD ;
FRANCIS, IR ;
KOROBKIN, M ;
SHAPIRO, B .
ENDOCRINE REVIEWS, 1995, 16 (04) :460-484
[7]   Extensive personal, experience - Adrenocortical tumors [J].
Latronico, AC ;
Chrousos, GP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (05) :1317-1324
[8]   Adrenal incidentaloma: An overview of hormonal data from the National Italian Study Group [J].
Mantero, F ;
Masini, AM ;
Opocher, G ;
Giovagnetti, M ;
Arnaldi, G .
HORMONE RESEARCH, 1997, 47 (4-6) :284-289
[9]  
MAUTHE I, 1977, KLIN PADIATR, V189, P172
[10]   CLINICAL REVIEW 54 - GENETICS, DIAGNOSIS, AND MANAGEMENT OF 21-HYDROXYLASE DEFICIENCY [J].
MILLER, WL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (02) :241-246